Cargando…

Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study

BACKGROUND: This study aimed to identify the cumulative incidence and risk factors of metachronous peritoneal metastasis (M‐PM) from colorectal cancer in patients who had intended curative treatment. METHODS: Patients with colorectal cancer were identified using the Danish Colorectal Cancer Group da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravn, S., Heide‐Jørgensen, U., Christiansen, C. F., Verwaal, V. J., Hagemann‐Madsen, R. H., Iversen, L. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093782/ https://www.ncbi.nlm.nih.gov/pubmed/32207578 http://dx.doi.org/10.1002/bjs5.50247

Ejemplares similares

The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries
por: Ravn, Sissel, et al.
Publicado: (2020)

Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin
por: van Oudheusden, T. R., et al.
Publicado: (2015)

Development and validation of a nomogram for predicting metachronous peritoneal metastasis in colorectal cancer: A retrospective study
por: Ban, Bo, et al.
Publicado: (2023)

Which patients are prone to suffer liver metastasis? A review of risk factors of metachronous liver metastasis of colorectal cancer
por: Hao, Mengdi, et al.
Publicado: (2022)

Nomogram for prediction of peritoneal metastasis risk in colorectal cancer
por: Song, Xian-qing, et al.
Publicado: (2022)

Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma
por: Dietz, Michelle V., et al.
Publicado: (2022)

Tumor size is an independent risk predictor for metachronous colorectal cancer
por: Kato, Takaharu, et al.
Publicado: (2016)

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021)

Risk factors predicting the occurrence of metachronous ovarian metastasis of gastric cancer
por: Gao, Jianpeng, et al.
Publicado: (2021)

Analysis of risk characteristics for metachronous metastasis in different period of nasopharyngeal carcinoma
por: Fei, Zhaodong, et al.
Publicado: (2023)

Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
por: Bakkers, C., et al.
Publicado: (2021)

Cancer follow-up supported by patient-reported outcomes in patients undergoing intended curative complex surgery for advanced cancer
por: Ravn, Sissel, et al.
Publicado: (2021)

Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer
por: Patel, Abhilasha, et al.
Publicado: (2017)

Multielectrode Radiofrequency Ablation for Resectable Metachronous Liver Metastasis from Colorectal Cancer
por: Cheng, Hou-Ying, et al.
Publicado: (2021)

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis
por: Li, Yue, et al.
Publicado: (2022)

Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases
por: Liu, Jin-Hwang, et al.
Publicado: (2010)

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers – the advantage of more extensive surgery
por: Parry, Susan, et al.
Publicado: (2011)

The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline
por: Lee, Seung Min, et al.
Publicado: (2015)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer
por: Lee, Byoung Chul, et al.
Publicado: (2016)

Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma
por: Jacobs, Elizabeth, et al.
Publicado: (2011)

Coexistent adenoma and serrated polyps on index colonoscopy and the risk of metachronous advanced colorectal neoplasia
por: Park, Soo-Kyung, et al.
Publicado: (2019)

Effects of Somatic Methylation in Colonic Polyps on Risk of Developing Metachronous Advanced Colorectal Lesions
por: Murcia, Oscar, et al.
Publicado: (2021)

Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy
por: Kim, Nam Hee, et al.
Publicado: (2021)

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
por: Jodal, Henriette C., et al.
Publicado: (2023)

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone
por: Mirnezami, R, et al.
Publicado: (2014)

Predicting metachronous liver metastasis in patients with colorectal cancer: development and assessment of a new nomogram
por: Hao, Mengdi, et al.
Publicado: (2022)

Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer
por: Horak, Josef, et al.
Publicado: (2023)

A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors
por: Tseng, Chao-Ming, et al.
Publicado: (2020)

Changes in Abdominal Obesity Affect the Risk of Metachronous Advanced Colorectal Neoplasia Development after Polypectomy
por: Jung, Yoon Suk, et al.
Publicado: (2020)

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort
por: Akdeniz, Delal, et al.
Publicado: (2022)

Case of metachronous clear cell bladder metastasis on low risk localized renal cell carcinoma patient
por: Adhiguna, Mahdy Alief, et al.
Publicado: (2022)

Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases
por: Ito, Kyoji, et al.
Publicado: (2019)

Incidence of and Risk Factors for Pediatric Metachronous Contralateral Inguinal Hernia: Analysis of a 17-Year Nationwide Database in Taiwan
por: Lee, Cheng-Hung, et al.
Publicado: (2016)

Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
por: Larsen, S. G., et al.
Publicado: (2021)

Metachronous colorectal liver metastasis that occurred 10 years after laparoscopic colectomy: a case report
por: Shidahara, Hidetoshi, et al.
Publicado: (2022)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Predictors of Metachronous Risk Polyps After Index Colonoscopy
por: Carot, Laura, et al.
Publicado: (2021)

Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma
por: Watanabe, Toshifumi, et al.
Publicado: (2017)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v04mcsmsla5i4muaea6npk10at